7 Recruiting Lymphoma, B-Cell Phase 1 Clinical Trials
Active phase 1 studies for lymphoma, b-cell enrolling across the USA. Verify eligibility and contact site coordinators.
All Lymphoma, B-Cell studiesPhase 1 Studies for Lymphoma, B-Cell
🔵 Active, Not Recruiting Phase1 / Phase2
A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)
📍 Mayo Clinic Hospital ( Site 0140) — Scottsdale, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
FT819 in Subjects With B-cell Malignancies
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Early Phase1
Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma
📍 BCCA - Vancouver — Vancouver, British Columbia
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma
📍 Local Institution - 162 — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase1
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
📍 City of Hope — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
📍 Colorado Blood Cancer Institute — Denver, Colorado
View Study & Checklist ➔ 🟢 Recruiting Phase1
Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas
📍 Levine Cancer Institute, Atrium Health — Charlotte, North Carolina
View Study & Checklist ➔